Results 261 to 270 of about 1,408,658 (292)

A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma. [PDF]

open access: yesMol Med
Chen CH   +10 more
europepmc   +1 more source

Xuetongsu attenuates synovial inflammation in rheumatoid arthritis by inhibiting the IL-23/IL-17/NF-κB inflammatory axis. [PDF]

open access: yesFront Pharmacol
Chen Y   +9 more
europepmc   +1 more source

Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study. [PDF]

open access: yesBMC Rheumatol
Ariani A   +63 more
europepmc   +1 more source

Kadar Interleukin (Il-17) Plasma yang Rendah Berkorelasi Negatif Terhadap Kejadian Kondiloma Akuminata Rekalsitran

open access: diamond
Revaniar Poetri Calvan   +5 more
openalex   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

IL-17 for therapy

Journal of Dermatological Science, 2017
The cytokine IL-17 is now a target for an array of therapeutic monoclonal antibodies supposed to treat a variety of inflammatory diseases. The forerunner Secukinumab, an IL-17A neutralizing antibody, is meanwhile approved as first-line treatments for moderate-to-severe plaque psoriasis, and as second-line treatment for psoriatic arthritis and ...
Florian C, Kurschus, Sonja, Moos
openaire   +2 more sources

IL-17 cytokine family

Journal of Allergy and Clinical Immunology, 2004
A new family of cytokines, IL-17, has recently been defined that reveals a distinct ligand-receptor signaling system. Functional studies have provided evidence for its importance in the regulation of immune responses. Notably, 3 members, IL-17A, IL-17E (IL-25), and IL-17F, have been best characterized both in vitro and in vivo , and have been shown to ...
Mio, Kawaguchi   +4 more
openaire   +2 more sources

IL-17 in human asthma

Expert Review of Respiratory Medicine, 2012
Asthma is perceived as a heterogeneous disease with several clinical phenotypes and triggering factors. In general, cytokines from T-helper 2 cells are believed to be critical contributors of asthma. In recent years, IL-17, another T-helper lymphocyte-associated cytokine, has been put forward as another potentially important mediator of asthma ...
Elin, Silverpil, Anders, Lindén
openaire   +2 more sources

Home - About - Disclaimer - Privacy